GAS5 and breast carcinoma: It is well known that GAS5 acts as tumor-suppressor in several malignancies and it was reported to be significantly lower in clinical renal cell carcinoma (RCC) specimens24, breast cancer tissues25 and HCC tissues26 when compared to the adjacent normal tissues.